Overview
While heart failure (HF) is a major healthcare problem in Hong Kong, stark differences have been observed in mortality and outcomes between patients with and without reductions in the cardiac biomarker N-terminal–pro hormone BNP (NT-proBNP).
In this module, we will:
Upon completion of this module, participants should be able to: